HCV genotype 2 and 3 infections: what is the optimal duration for peginterferon alpha-2b and ribavirin therapy?

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/0ADCF334.svg?ark=w1%2F20260515%2F0ADCF334)](https://nobleid.org/work/w1/20260515/0ADCF334)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors